JPH0449229A - Composition for cutis - Google Patents

Composition for cutis

Info

Publication number
JPH0449229A
JPH0449229A JP2160665A JP16066590A JPH0449229A JP H0449229 A JPH0449229 A JP H0449229A JP 2160665 A JP2160665 A JP 2160665A JP 16066590 A JP16066590 A JP 16066590A JP H0449229 A JPH0449229 A JP H0449229A
Authority
JP
Japan
Prior art keywords
fibers
cutis
skin
liquid drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2160665A
Other languages
Japanese (ja)
Other versions
JPH0741062B2 (en
Inventor
Kenji Arase
荒瀬 賢司
Michio Hanai
花井 道夫
Masahiro Nakamura
匡宏 中村
Rioko Nishida
西田 理緒子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakodo Co Ltd
Original Assignee
Wakodo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakodo Co Ltd filed Critical Wakodo Co Ltd
Priority to JP2160665A priority Critical patent/JPH0741062B2/en
Publication of JPH0449229A publication Critical patent/JPH0449229A/en
Publication of JPH0741062B2 publication Critical patent/JPH0741062B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To provide a composition substantially not adsorbing a liquid drug, capable of sufficiently exhibiting the activity of the drug, having excellent touch to skin and useful for cutis, by allowing a carrier to absorb the liquid drug containing a sterilizer, the carrier comprising chemical fibers containing polyester fibers. CONSTITUTION:A liquid drug used for cutis and comprising a sterilizer such as benzalkonium chloride or chlorohexidine glyconate as a main ingredient and other ingredient such as naphazoline chloride or dipcain chloride dissolved in water is impregnated into a carrier comprising a chemical fiber article containing polyester fibers, such as a non-woven fabric comprising the polyester fibers or a mixture thereof with other fibers to provide a composition for cutis. The composition substantially not adsorb the liquid drug on the fibers compared with conventional compositions, is useful for cutis and is used for sterilized disinfected cotton, towel, wound-protecting materials such as emergency adhesive tapes or sterilized gauze, analgestic, antipruritic, astringent, and antiphlogistic agents, cataplasm, anhidrotic agent, puppurative diseases, etc.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、外皮用組成物に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to dermal compositions.

さらに詳しくは、担体として、ポリエステル繊維、また
はポリエステル繊維と他の繊維との混合物からなる不織
布を選び、これに殺菌剤を含む外皮用液剤を吸収させた
外皮用組成物に関する。
More specifically, the present invention relates to a skin composition in which a nonwoven fabric made of polyester fibers or a mixture of polyester fibers and other fibers is selected as a carrier, and a skin liquid containing a fungicide is absorbed therein.

[従来の技術] 従来クロルヘキシジン、塩化ベンザルコニウム等の外皮
用殺菌剤溶液を脱脂綿、ガーゼ等のセルロース繊維に吸
収させたものが、皮膚の殺菌消毒に用いられてきた。
[Prior Art] Conventionally, a solution of a skin disinfectant such as chlorhexidine or benzalkonium chloride absorbed into cellulose fibers such as absorbent cotton or gauze has been used to disinfect and disinfect the skin.

しかし、これらの殺菌消毒組成物は、薬剤のほとんとか
セルロース繊維に吸着し、薬剤の効果が著しく低下する
ことが知られていた。
However, it has been known that most of the drugs in these sterilizing and disinfecting compositions are adsorbed to cellulose fibers, significantly reducing the effectiveness of the drugs.

かかる解決方法として、特開昭50−18616号公報
、および特開昭50−18617号公報に示されるよう
に、2価以上の金属塩あるいは高級アルコール硫酸エス
テル塩を添加する方法があった。
As a method for solving this problem, there has been a method of adding a divalent or higher valent metal salt or a higher alcohol sulfate ester salt, as shown in JP-A-50-18616 and JP-A-50-18617.

しかしながら、これらの方法はいずれも完全に満足し得
るものではなく、例えば2価以上の金属塩の添加におい
ては、吸着防止効果の良い塩化カルシウムは局所刺激が
強く、また塩化マグネシウムは苦味が非常に強いため、
例えば乳首の清拭には使用できないという欠点を有した
However, none of these methods are completely satisfactory; for example, when adding divalent or higher valent metal salts, calcium chloride, which has a good adsorption prevention effect, causes strong local irritation, and magnesium chloride has a very bitter taste. Because it is strong,
For example, it had the disadvantage that it could not be used to clean nipples.

一方、高級アルコール硫酸エステル塩の添加においては
、外皮用殺菌剤の殺菌力が減退するという問題があり、
また、高級アルコール硫酸エステル塩自体も皮膚に対し
て好ましくない作用(浸透性、刺激性)を有する。
On the other hand, when adding higher alcohol sulfate ester salts, there is a problem in that the bactericidal activity of the skin fungicide decreases.
Further, higher alcohol sulfate salts themselves have unfavorable effects on the skin (penetration, irritation).

更に、これらの吸着防止法として、特開昭621986
9号公報に記載されたような、1価の金属塩(例えば塩
化ナトリウム)を添加する方法があリ、これによりセル
ロース、綿からのクロルヘキシジングルコネート等の外
皮用殺菌剤の吸着をある程度防止できるが、完全な形で
吸着防止はできない。
Furthermore, as a method for preventing these adsorptions, Japanese Patent Application Laid-Open No. 621986
There is a method of adding a monovalent metal salt (for example, sodium chloride) as described in Publication No. 9, which can prevent to some extent the adsorption of skin fungicides such as chlorhexidine gluconate from cellulose and cotton. However, it is not possible to completely prevent adsorption.

[発明が解決しようとする課題] 上記のような添加剤を配合せず、しかも、良好に薬剤を
溶出させることについて、永年に亘り検討した結果、坦
体として化学繊維、特にポリエステル繊維を用いた場合
に殺菌剤を含む外皮用液剤がほとんど吸着されず、有効
成分の効果を十分に発揮できることを見い出し、発明を
完成した。
[Problem to be solved by the invention] As a result of many years of study on how to elute drugs well without adding the above additives, we have developed a method using chemical fibers, especially polyester fibers, as carriers. The inventors completed the invention by discovering that in some cases, a liquid preparation for the skin containing a bactericide is hardly adsorbed, and the effect of the active ingredient can be fully exerted.

[構成] 本発明の外皮組成物は殺菌剤を含む外皮用液剤を吸収さ
せた、ポリエステル繊維を含む化学繊維素材よりなる。
[Structure] The skin composition of the present invention is made of a chemical fiber material containing polyester fibers, which has been absorbed with a liquid agent for skin containing a fungicide.

上記、「ポリエステル繊維を含む、化学繊維素材」とは
、殺菌剤を含む外皮用液剤をほとんど吸着しないポリエ
ステル繊維が、繊維の表面を、十分な程度に覆っている
化学繊維素材であり、例えば、 (1)ポリエステル繊維のみからなる素材、(2)熱融
着繊維の如く、他の化学繊維を繊維芯材として用い、さ
や成分としてポリエステルを使用した素材、 (3)ポリエステル繊維とを他の化学繊維とを混綿した
素材 等を挙げることができ、従って、ポリエステル繊維と他
の化学繊維とをそれぞれ0〜100%の比率で混合する
ことができる。
The above-mentioned "chemical fiber material containing polyester fibers" is a chemical fiber material in which the surface of the fibers is sufficiently covered with polyester fibers that hardly absorb liquid agents for outer skin containing disinfectants. (1) Materials consisting only of polyester fibers, (2) Materials that use other chemical fibers as the fiber core material and polyester as the sheath component, such as heat-fused fibers, (3) Materials that use polyester fibers and other chemical fibers as the sheath component. Examples include materials in which polyester fibers are mixed with other chemical fibers, and therefore, polyester fibers and other chemical fibers can be mixed at a ratio of 0 to 100%, respectively.

ここで、「他の化学繊維」とは、ポリエチレン、レーヨ
ン、ナイロン、ポリプロピレン、ビニロン、ポリアミド
のような化学繊維を挙げることができる。
Here, "other chemical fibers" include chemical fibers such as polyethylene, rayon, nylon, polypropylene, vinylon, and polyamide.

なお、化学繊維素材は不織布であることが好ましく、更
にかかる不織布は皮膚への触感がよく、耐薬品性があり
、液体の吸蔵能が大きく、かつ内容成分が吸着されない
特性を有することが好ましい。
The chemical fiber material is preferably a non-woven fabric, and it is further preferable that such a non-woven fabric feels good on the skin, has chemical resistance, has a large liquid storage capacity, and has the characteristics that the contents are not adsorbed.

例えばポリエステル不織布では、目付40〜44mg/
II+2、厚さ0.46a+fflの不織布は1g当た
り6〜8fflLの液体で吸蔵させることが好適である
For example, polyester nonwoven fabric has a basis weight of 40 to 44 mg/
It is suitable that the nonwoven fabric having a thickness of II+2 and a thickness of 0.46a+ffl is occluded with 6 to 8 ffl/g of liquid.

前記「殺菌剤を含む外皮用液剤」とは、主剤として、殺
菌剤を含む外皮用液剤をいい、かかる「殺菌剤」として
は、例えば塩化ベンザルコニウム、塩化ベンゼトニウム
、塩酸クロルヘキシジン、クロルヘキシジングルコネー
ト、ポビドンヨード、アクリノール、塩化デカリニウム
、セトノミドのようなイオン性の殺菌剤を挙げることが
できる。
The above-mentioned "liquid for skin containing a bactericide" refers to a liquid for skin that contains a bactericide as a main ingredient, and such "bactericide" includes, for example, benzalkonium chloride, benzethonium chloride, chlorhexidine hydrochloride, chlorhexidine gluconate, Mention may be made of ionic fungicides such as povidone-iodine, acrinol, dequalinium chloride, cetonomide.

なお、「殺菌剤を含む外皮用液剤」は外皮用薬剤におい
て、一般に使用される他の薬剤を含んでいても良く、か
かる薬剤としては、アミノ安息香酸エチル、ジブカイン
(またはその塩酸塩)、プロ力イン(またはその塩酸塩
)、リドカイン(またはその塩酸塩)、グリチルリチン
酸(またはその塩)、クリチルレチン酸、インドメタシ
ン、副腎皮質ステロイド剤のような局所麻酔、鎮痛・消
炎剤、塩酸テトラゾリン、塩酸ナファゾリン、塩酸フェ
ニレフリン、dff−塩酸メチルエフェドリン、塩酸エ
ピネフリンのような血管収縮剤、マレイン酸クロルフェ
ニラミン、ジフェンヒドラミン(またはその塩)、塩酸
イソチペンジルのような抗ヒスタミン剤、酸化亜鉛、カ
ラミン、硫酸アルミニウムカリウム、アラントイン、ア
ルミニクムクロルヒドロキシアラントイネート等のアラ
ントインの誘導体のような収斂剤、クロタミトン、メン
トール、カンフル、サリチル酸メチルのような鎮痒剤、
およびビタミン類、また、安息香酸およびそのナトリウ
ム塩、パラオキシ安息香酸メチル、パラオキシ安息香酸
エチル、パラオキシ安息香酸プロピル、バラオキシ安息
香酸イソプロピル、バラオキシ安息香酸ブチル、バラオ
キシ安息香酸イソブチル、ソルビン酸およびそのカリウ
ム塩、デヒドロ酢酸およびそのナトリウム塩、プロピオ
ン酸カルシウム、プロピオン酸ナトリウムのような防腐
剤を挙げることができる。
The "liquid for skin containing a bactericide" may also contain other drugs commonly used for skin, such as ethyl aminobenzoate, dibucaine (or its hydrochloride), probiotics, etc. Local anesthetics, analgesics and anti-inflammatories such as Licoin (or its hydrochloride), lidocaine (or its hydrochloride), glycyrrhizic acid (or its salts), clycyrrhetinic acid, indomethacin, corticosteroids, tetrazoline hydrochloride, naphazoline hydrochloride , phenylephrine hydrochloride, dff-methylephedrine hydrochloride, vasoconstrictors such as epinephrine hydrochloride, chlorpheniramine maleate, diphenhydramine (or its salts), antihistamines such as isothipendyl hydrochloride, zinc oxide, calamine, potassium aluminum sulfate, allantoin, astringents such as derivatives of allantoin such as aluminum chlorhydroxyallantoinate, antipruritics such as crotamiton, menthol, camphor, methyl salicylate;
and vitamins, as well as benzoic acid and its sodium salt, methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, isopropyl paraoxybenzoate, butyl paraoxybenzoate, isobutyl paraoxybenzoate, sorbic acid and its potassium salt, Mention may be made of preservatives such as dehydroacetic acid and its sodium salt, calcium propionate, sodium propionate.

また、「殺菌剤を含む外皮用液剤」に配合される薬剤の
濃度は、一般に医薬品、医薬部外品および化粧品に汎用
されている配合量で良い。
Furthermore, the concentration of the drug added to the "liquid for skin containing a bactericide" may be the amount commonly used in pharmaceuticals, quasi-drugs, and cosmetics.

外皮用液剤の溶媒としては、上記を溶解し、かつ皮膚刺
激の少ないものが使用でき、例えば水、含水エタノール
、マクロゴール、グルセリン、プロピレングリコールの
ような水性溶媒、ミグリオール、トウモロコシ油、ラッ
カセイ油、オリーブ油、ナタネ油、ゴマ油、流動パラフ
ィンのような油性溶媒を挙げることができる。
As the solvent for the liquid preparation for the skin, those that dissolve the above and are less irritating to the skin can be used, such as water, aqueous solvents such as hydrated ethanol, macrogol, glycerin, and propylene glycol, miglyol, corn oil, peanut oil, Mention may be made of oily solvents such as olive oil, rapeseed oil, sesame oil, liquid paraffin.

[効果] 以下の試験例に示すように、本発明の組成物たるポリエ
ステル単独あるいは、ポリエステル繊維とレーヨンから
なる繊維は、従来のセルロース繊維のみからなる綿に比
べて、吸着はほとんど認められず、皮膚への触感が優れ
る。
[Effects] As shown in the test examples below, the composition of the present invention, which is polyester alone or fibers made of polyester fibers and rayon, exhibits almost no adsorption compared to conventional cotton made only of cellulose fibers. Excellent feel to the skin.

[試験例] 試験例における残存率は次の方法にて求めた。[Test example] The survival rate in the test example was determined by the following method.

l)塩化ベンザルコニウム 含浸液および絞り液各々311に内標準液(塩酸ジフェ
ンヒドラミン0.1%液)を加え、精製水で正確に10
+nlとし、各々30μmについて液体クロマトグラフ
法により試験を行い、内標準物質のピーク面積に対する
塩化ベンザルコニウムのピーク面積比Qt(絞り液)お
よびQs(含浸液)を求め算出した。
l) Add an internal standard solution (diphenhydramine hydrochloride 0.1% solution) to 311 ml of each of the benzalkonium chloride impregnating solution and squeezing solution, and dilute to exactly 10 ml with purified water.
+nl, and a test was conducted by liquid chromatography for each 30 μm, and the peak area ratios Qt (squeezing solution) and Qs (impregnating solution) of benzalkonium chloride to the peak area of the internal standard substance were determined and calculated.

残存率(%)−〇t Qs   X100 2)塩酸ナファゾリン、塩酸ジブヵイン含浸液および絞
り液111に内標準液(塩酸プロ力イン0.1%溶液)
1mlを加え、精製水で正確に25a+1とし、各々2
0μmについて液体クロマトグラフ法により試験を行い
、内標準物質のピーク面積に対する各薬剤のビークコ積
比qt(絞り液)および(ls(含浸液)′を求め、次
式により残存率を算出した。
Residual rate (%) -〇t Qs
Add 1ml, make exactly 25a+1 with purified water, and make 25a+1 each.
A test was conducted using liquid chromatography at 0 μm, and the beak volume ratios qt (squeezing solution) and (ls (impregnating solution)) of each drug to the peak area of the internal standard were determined, and the residual rate was calculated using the following formula.

残存率(%)−〇t Qsxloo 3)クロルヘキシジングルコネート 含浸液および絞り液の各々200L11を水で希釈して
20m1とした。
Residual rate (%) -〇t Qsxloo 3) 200L11 of each of the chlorhexidine gluconate impregnating liquid and squeezing liquid was diluted with water to make 20ml.

水を対照として、波長197nfflにおける吸光度E
t (絞り液)およびEs (標準液)を測定し、残存
率を算出した。
Absorbance E at wavelength 197nffl with water as a control
t (squeezed liquid) and Es (standard solution) were measured, and the residual rate was calculated.

4)塩酸プロ力イン 含浸液および絞り液の各々に内標準液(塩酸プロ力イン
0,1%溶液)3mlを加え、移動相で20m1とした
。試料溶液および標準溶液20μmにつき液体クロマト
グラフ法で試験を行い、内標準物質のピーク面積に対す
る塩酸プロ力インのピーク面積の比Qt(絞り液)およ
びQs (含浸液)を求め、残存率を算出した。
4) 3 ml of an internal standard solution (0.1% solution of hydrochloric acid propylene) was added to each of the hydrochloric acid propylene impregnating solution and the squeezing solution, and the total volume was made up to 20 ml with the mobile phase. Test the sample solution and standard solution with a liquid chromatography method of 20 μm, determine the ratio of the peak area of pro-hydrochloric acid to the peak area of the internal standard substance, Qt (squeezing solution) and Qs (impregnating solution), and calculate the residual rate. did.

5)アラントイン 局外規のアラントイン定量法を適用。5) Allantoin The allantoin quantitative method prescribed by the local government was applied.

[試験例1] 塩化ベンザルコニウムの0.1%溶液を調製し、その1
mlを種々の化学繊維からなる不織布0.15gに含浸
させ、アルミラミネート袋に密封し、室温で72時間ま
で放置したときの絞り液中の塩化ベンザルコニウムの残
存率の経時変化をみた。
[Test Example 1] Prepare a 0.1% solution of benzalkonium chloride, Part 1
ml was impregnated into 0.15 g of nonwoven fabric made of various chemical fibers, sealed in an aluminum laminate bag, and left at room temperature for up to 72 hours. Changes in the residual rate of benzalkonium chloride in the squeezing solution over time were observed.

表1から明らかなように、種々の化学繊維からなる不織
布からの塩化ベンザルコニウムの各時間における残存率
の変化をみると、4時間で吸着が平衡状態となり、化学
繊維からなる不織布は、局方脱脂綿に比較し、明らかに
残存率の差がみられた。
As is clear from Table 1, looking at the changes in the residual rate of benzalkonium chloride from nonwoven fabrics made of various chemical fibers over time, the adsorption reached an equilibrium state in 4 hours, and the nonwoven fabric made of chemical fibers There was a clear difference in the residual rate compared to cotton wool.

[試験例2] 各実施例等の組成物の、含浸4時間後の絞り液表2に示
すように、各薬剤の残存率を本発明外皮用組成物と対照
を比較すると、本発明の組成物は吸着率が著しく低く、
よって効果は優れていることが明らかである。
[Test Example 2] Squeezed liquid after 4 hours of impregnation of the compositions of each example, etc. As shown in Table 2, when the residual rate of each drug was compared between the skin composition of the present invention and the control, it was found that the composition of the present invention The adsorption rate of substances is extremely low;
Therefore, it is clear that the effect is excellent.

し試験例3] 各実施例等の組成物の含浸4時間後の絞り液を表3に示
すように、各薬剤の残存率を本発明外皮用組成物と、対
照を比較すると、本発明の組成物は、吸着率が著しく低
く、よって効果は優れていることが明らかである。
[Test Example 3] As shown in Table 3, the squeezed liquid after 4 hours of impregnation with the compositions of each example, etc., shows that when the residual rate of each drug is compared with the skin composition of the present invention and the control, it is found that It is clear that the composition has a significantly lower adsorption rate and therefore its effectiveness is excellent.

以上のように本願発明の外皮用組成物は、従来の組成物
と比較し、繊維への吸着が殆どなく、外皮用として有用
な組成物である。
As described above, the composition for outer skin of the present invention has almost no adsorption to fibers than conventional compositions, and is a useful composition for outer skin.

従って本発明の組成物は、殺菌消毒綿、おてふき、創傷
保護剤(救急絆創膏、殺菌ガーゼ)、鎮痛・鎮痒・収斂
・消炎剤(かゆみ止め等)、パップ剤、寄生性皮膚疾患
剤(みすむし薬)、褥瘉治療剤、痔疾用剤、制汗・消臭
剤、化膿性疾患用剤および経皮吸収剤として用いること
ができる。
Therefore, the composition of the present invention can be used as sterilizing cotton, towelettes, wound protectants (emergency bandages, sterile gauze), analgesic, antipruritic, astringent, and antiinflammatory agents (anti-itching agents, etc.), poultices, parasitic skin disease agents ( It can be used as a decubitus ulcer treatment agent, a hemorrhoid agent, an antiperspirant/deodorant, an agent for purulent diseases, and a transdermal absorption agent.

[製造例] 次に製造例等をあげて、本発明を更に具体的に説明する
が、本発明はこれによって限定されるものではない。
[Production Examples] Next, the present invention will be explained in more detail with reference to Production Examples, but the present invention is not limited thereto.

対照例1 塩化ベンザルコニウムo、 Ig、塩酸ナファゾリン0
.1g、塩酸ジブカイン0.1gを蒸留水に溶解し、全
量を100m1とした。この液1+nlを局方脱脂綿’
0.15gに含浸させた後、アルミラミネート袋に密封
した。
Control example 1 Benzalkonium chloride o, Ig, naphazoline hydrochloride 0
.. 1 g of dibucaine hydrochloride and 0.1 g of dibucaine hydrochloride were dissolved in distilled water to make a total volume of 100 ml. Dispense 1+nl of this solution onto a pharmacologically absorbent cotton pad.
After impregnating 0.15 g, it was sealed in an aluminum laminate bag.

実施例1 塩化ベンザルコニウム0.1g、塩酸ナファゾリン0、
1g、塩酸ジブカインQ、 Igを蒸留水に溶解し、全
量を100m+1とした。この液1+nlをポリエステ
ル100%からなる不織布0.15gに含浸させた後、
アルミラミネート袋に密封した。
Example 1 Benzalkonium chloride 0.1 g, naphazoline hydrochloride 0,
1 g of dibucaine hydrochloride Q and Ig were dissolved in distilled water, and the total amount was adjusted to 100 m+1. After impregnating 0.15 g of a nonwoven fabric made of 100% polyester with 1+nl of this liquid,
Sealed in an aluminum laminated bag.

実施例2 塩化ベンザルコニウム0.1g、塩酸ナファゾリン0.
1g、塩酸ジブカインO,Igを蒸留水に溶解し、全量
を100m1とした。この液1mlをポリエステル70
%およびレーヨン30%からなる不織布0.15gに含
浸させた後、アルミラミネート袋に密封した。
Example 2 0.1 g of benzalkonium chloride, 0.1 g of naphazoline hydrochloride.
1 g of dibucaine hydrochloride O, Ig was dissolved in distilled water, and the total volume was adjusted to 100 ml. Add 1 ml of this solution to polyester 70
After impregnating 0.15 g of a nonwoven fabric consisting of 30% and 30% rayon, it was sealed in an aluminum laminate bag.

実施例3 塩化ベンザルコニウム0.1g、塩酸ナファゾリン0.
1巳、塩酸ジブカイン0.1gを蒸留水に溶解し、全量
を100 ff1lとした。この液1+nlをポリエス
テル50%およびポリエチレン50%からなる不織布0
.15gに含浸させた後、アルミラミネート袋に密封し
た。
Example 3 0.1 g of benzalkonium chloride, 0.1 g of naphazoline hydrochloride.
0.1 g of dibucaine hydrochloride was dissolved in distilled water, and the total amount was adjusted to 100 ffl. 1+nl of this solution was applied to a nonwoven fabric made of 50% polyester and 50% polyethylene.
.. After impregnating 15 g, it was sealed in an aluminum laminate bag.

対照例2 クロルヘキシジングルコネート0.1g、塩酸プロ力イ
ン1g、アラントイン0.1gを蒸留水に溶解し、全量
を100 mlとした。この液1a+1を局方脱脂綿0
.15gに含浸させた後、アルミラミネート袋に密封し
た。
Control Example 2 0.1 g of chlorhexidine gluconate, 1 g of prolactin hydrochloride, and 0.1 g of allantoin were dissolved in distilled water to make a total volume of 100 ml. Add this solution 1a+1 to 0% cotton
.. After impregnating 15 g, it was sealed in an aluminum laminate bag.

実施例4 クロルヘキシジングルコネート0.1g、塩酸プロ力イ
ン1g、アラントイン0.1gを蒸留水に溶解し、全量
を100 mlとした。この液1a+1をポリエステル
100%からなる不織布0.15gに含浸させた後、ア
ルミラミネート袋に密封した。
Example 4 0.1 g of chlorhexidine gluconate, 1 g of propyroin hydrochloride, and 0.1 g of allantoin were dissolved in distilled water to make a total volume of 100 ml. After impregnating 0.15 g of a nonwoven fabric made of 100% polyester with this liquid 1a+1, it was sealed in an aluminum laminate bag.

実施例5 クロルヘキシジングルコネート0.1g、塩酸プロ力イ
ン1g、アラントインO,Igを蒸留水に溶解し、全量
を100 mlとした。この液Lo11をポリエステル
70%およびレーヨン30%からなる不織布0.15g
に含浸させた後、アルミラミネート袋に密封した。
Example 5 0.1 g of chlorhexidine gluconate, 1 g of propylene hydrochloride, and allantoin O and Ig were dissolved in distilled water to make a total volume of 100 ml. 0.15g of this liquid Lo11 was added to a nonwoven fabric made of 70% polyester and 30% rayon.
After impregnating it with water, it was sealed in an aluminum laminated bag.

実施例6 クロルヘキシジングルコネートO,1g、塩酸プロ力イ
ン1g、アラントイン0.1[を蒸留水に溶解し、全量
を100 mlとした。この液1mlをポリエステル5
0%およびポリエチレン50%がらな5不織布0.15
gに含浸させた後、アルミラミネート袋に密封した。
Example 6 1 g of chlorhexidine gluconate O, 1 g of propyroin hydrochloride, and 0.1 g of allantoin were dissolved in distilled water to make a total volume of 100 ml. Add 1 ml of this solution to polyester 5
0% and 50% polyethylene non-woven fabric 0.15
After impregnating it with g, it was sealed in an aluminum laminate bag.

出願人     和光堂株式会社 代理人 弁理士 大 野 彰 夫Applicant: Wakodo Co., Ltd. Agent: Patent Attorney Akio Ohno

Claims (1)

【特許請求の範囲】[Claims] ポリエステル繊維を含む化学繊維素材に、殺菌剤を含む
外皮用液剤を吸収させることよりなる外皮用組成物。
A composition for skins made by absorbing a liquid agent for skins containing a fungicide into a chemical fiber material containing polyester fibers.
JP2160665A 1990-06-19 1990-06-19 Composition for outer skin Expired - Fee Related JPH0741062B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2160665A JPH0741062B2 (en) 1990-06-19 1990-06-19 Composition for outer skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2160665A JPH0741062B2 (en) 1990-06-19 1990-06-19 Composition for outer skin

Publications (2)

Publication Number Publication Date
JPH0449229A true JPH0449229A (en) 1992-02-18
JPH0741062B2 JPH0741062B2 (en) 1995-05-10

Family

ID=15719845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2160665A Expired - Fee Related JPH0741062B2 (en) 1990-06-19 1990-06-19 Composition for outer skin

Country Status (1)

Country Link
JP (1) JPH0741062B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701397A1 (en) * 1993-02-12 1994-08-19 Lemaire Henry Product for topical administration of medicinal or cosmetic substances
US5591052A (en) * 1994-06-23 1997-01-07 Yazaki Corporation Connector with a double locking mechanism
US7427574B2 (en) * 2005-08-19 2008-09-23 Sage Products, Inc. Non-woven wash cloth
JP2009256338A (en) * 2008-03-24 2009-11-05 Asahi Kasei Chemicals Corp Sterilizing disinfectant-containing wet wiper
US7823727B2 (en) 2005-06-29 2010-11-02 Sage Products, Inc. Patient check system
JP2012514641A (en) * 2009-01-06 2012-06-28 ベクトン・ディキンソン・アンド・カンパニー Chlorhexidine acetate disinfectant cleaner
JP2019097756A (en) * 2017-11-30 2019-06-24 株式会社ニイタカ Wet wiper

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102495182A (en) * 2011-12-15 2012-06-13 上海景峰制药有限公司 Novel quantitative germicidal test carrier for disinfectant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6411556A (en) * 1987-07-03 1989-01-17 Teisan Seiyaku Kk Injury protecting agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6411556A (en) * 1987-07-03 1989-01-17 Teisan Seiyaku Kk Injury protecting agent

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701397A1 (en) * 1993-02-12 1994-08-19 Lemaire Henry Product for topical administration of medicinal or cosmetic substances
US5591052A (en) * 1994-06-23 1997-01-07 Yazaki Corporation Connector with a double locking mechanism
US7823727B2 (en) 2005-06-29 2010-11-02 Sage Products, Inc. Patient check system
US7427574B2 (en) * 2005-08-19 2008-09-23 Sage Products, Inc. Non-woven wash cloth
JP2009256338A (en) * 2008-03-24 2009-11-05 Asahi Kasei Chemicals Corp Sterilizing disinfectant-containing wet wiper
JP2012514641A (en) * 2009-01-06 2012-06-28 ベクトン・ディキンソン・アンド・カンパニー Chlorhexidine acetate disinfectant cleaner
JP2019097756A (en) * 2017-11-30 2019-06-24 株式会社ニイタカ Wet wiper

Also Published As

Publication number Publication date
JPH0741062B2 (en) 1995-05-10

Similar Documents

Publication Publication Date Title
AU2014203072B2 (en) Topical glycopyrrolate formulations
KR101393853B1 (en) Transdermal delivery of oleocanthal for relief of inflammation
US3624224A (en) Novel first aid products
US5665378A (en) Transdermal therapeutic formulation
JP5693470B2 (en) Disinfectant composition containing silver ions and menthol and use thereof
WO2001047559A9 (en) Patches for external use
CA1238275A (en) Menthol enhancement of transdermal drug delivery
JP6554474B2 (en) Traumatic wound dressing system including wrap
JPH0449229A (en) Composition for cutis
JP2000191521A (en) Sterilizer
JP2002212105A (en) Aqueous skin care composition
JP2004210668A (en) Medicine composition for external use
US20120061267A1 (en) MediTowel Anti-Fungal Wipe
JPH08109137A (en) Capsule, thin sheet for storing medicine, bag-like formulation and production thereof and method for administrating bag-like formulation
EP0918521B1 (en) Formulation for the treatment and/or prophylaxis of dementia
JP2002145762A (en) Wet tissue-type liniment, packaged wet tissue-type liniment and method for applying
WO2003026710A1 (en) Mixture for use as a protective dressing
JP2003040703A (en) Noxious insect-repelling agent for human body
RU2171694C1 (en) Medical product
JP2540861B2 (en) Poultice
JPH01313062A (en) External remedy for cold
RU35717U1 (en) Disposable sanitizer (options)
AU721101C (en) Formulation for the treatment and/or prophylaxis of dementia
IL34659A (en) An antiseptic composition comprising a germicidal quaternary ammonium compound,a poly(oxyethylene)-poly(oxypropylene)-block polymer and a local anaesthetic
Wang et al. Over-the-Counter Medications: Toxic Effects and Adverse Reactions: Part I

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080510

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090510

Year of fee payment: 14

LAPS Cancellation because of no payment of annual fees